By Patrick Thomas 
 

Roche Holdings Ltd. (RHHBY) will pay $21 million patent infringement settlement to Enzo Biochem Inc., Enzo said in a filing with the U.S. Securities and Exchange Commission Monday.

In its 2012 lawsuit, Enzo, a biotechnology company, said that Roche sold certain nucleic acid products in the U.S. used for genetic testing for diseases. The settlement, agreed on by the companies last week, involves several of Roche Holdings' subsidiaries, Roche Diagnostics GmbH and Roche Molecular Systems that make medical equipment.

Enzo said in the filing that this settlement doesn't affect its civil action for patent infringement against Roche in the U.S. District Court for the State of Delaware.

Representatives from Enzo and Roche couldn't be immediately reached for comment.

 

Write to Patrick Thomas at patrick.thomas@wsj.com

 

(END) Dow Jones Newswires

February 11, 2019 14:36 ET (19:36 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2020 to May 2020 Click Here for more Roche (QX) Charts.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From May 2019 to May 2020 Click Here for more Roche (QX) Charts.